185 related articles for article (PubMed ID: 38693868)
21. Antimalarial drug discovery against malaria parasites through haplopine modification: An advanced computational approach.
Akash S; Abdelkrim G; Bayil I; Hosen ME; Mukerjee N; Shater AF; Saleh FM; Albadrani GM; Al-Ghadi MQ; Abdel-Daim MM; Tok TT
J Cell Mol Med; 2023 Oct; 27(20):3168-3188. PubMed ID: 37724615
[TBL] [Abstract][Full Text] [Related]
22. Rebamipide attenuates Helicobacter pylori CagA-induced self-renewal capacity via modulation of β-catenin signaling axis in gastric cancer-initiating cells.
Kang DW; Noh YN; Hwang WC; Choi KY; Min do S
Biochem Pharmacol; 2016 Aug; 113():36-44. PubMed ID: 27265143
[TBL] [Abstract][Full Text] [Related]
23. Carcinogenic role of tumor necrosis factor-alpha inducing protein of Helicobacter pylori in human stomach.
Suganuma M; Kuzuhara T; Yamaguchi K; Fujiki H
J Biochem Mol Biol; 2006 Jan; 39(1):1-8. PubMed ID: 16466631
[TBL] [Abstract][Full Text] [Related]
24. Protein-protein docking and molecular dynamics studies of sericin and cocoonase of silkworm: an insight for cocoon softening.
Tiwari NP; Pandey JP; Pandey DM
J Biomol Struct Dyn; 2023 Mar; 41(4):1193-1205. PubMed ID: 34939532
[TBL] [Abstract][Full Text] [Related]
25. Targeting Helicobacter pylori in gastric carcinogenesis.
Lee DS; Moss SF
Expert Opin Ther Targets; 2007 Jun; 11(6):757-69. PubMed ID: 17504014
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel drug targets in HpB38, HpP12, HpG27, Hpshi470, HpSJM180 strains of Helicobacter pylori : an in silico approach for therapeutic intervention.
Neelapu NR; Pavani T
Curr Drug Targets; 2013 May; 14(5):601-11. PubMed ID: 23410125
[TBL] [Abstract][Full Text] [Related]
27. Statins Attenuate Helicobacter pylori CagA Translocation and Reduce Incidence of Gastric Cancer: In Vitro and Population-Based Case-Control Studies.
Lin CJ; Liao WC; Lin HJ; Hsu YM; Lin CL; Chen YA; Feng CL; Chen CJ; Kao MC; Lai CH; Kao CH
PLoS One; 2016; 11(1):e0146432. PubMed ID: 26730715
[TBL] [Abstract][Full Text] [Related]
28. Natural Isatin Derivatives Against Black Fungus: In Silico Studies.
Hossain MS; Rahman MA; Dey PR; Khandocar MP; Ali MY; Snigdha M; Coutinho HDM; Islam MT
Curr Microbiol; 2024 Mar; 81(5):113. PubMed ID: 38472456
[TBL] [Abstract][Full Text] [Related]
29. TNF-alpha-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells.
Suganuma M; Yamaguchi K; Ono Y; Matsumoto H; Hayashi T; Ogawa T; Imai K; Kuzuhara T; Nishizono A; Fujiki H
Int J Cancer; 2008 Jul; 123(1):117-22. PubMed ID: 18412243
[TBL] [Abstract][Full Text] [Related]
30. Developing Hispolon-based novel anticancer therapeutics against human (NF-κβ) using
Paul M; Kumar Panda M; Thatoi H
J Biomol Struct Dyn; 2019 Sep; 37(15):3947-3967. PubMed ID: 30295165
[TBL] [Abstract][Full Text] [Related]
31. Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer.
Reza MN; Mahmud S; Ferdous N; Ahammad I; Hossain MU; Al Amin M; Mohiuddin AKM
Cancer Med; 2023 Dec; 12(24):22407-22419. PubMed ID: 38037736
[TBL] [Abstract][Full Text] [Related]
32. Integrative computational protocol for the discovery of inhibitors of the Helicobacter pylori nickel response regulator (NikR).
Segura-Cabrera A; Guo X; Rojo-Domínguez A; Rodríguez-Pérez MA
J Mol Model; 2011 Dec; 17(12):3075-84. PubMed ID: 21360181
[TBL] [Abstract][Full Text] [Related]
33. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and bioevaluation of novel unsaturated cyanoacetamide derivatives: In vitro and in silico exploration.
Uddin KM; Meem MH; Akter M; Rahman S; Al-Gawati MA; Alarifi N; Albrithen H; Alodhayb A; Poirier RA; Bhuiyan MMH
MethodsX; 2024 Jun; 12():102691. PubMed ID: 38660042
[TBL] [Abstract][Full Text] [Related]
35. In silico identification and analysis of potential inhibitors for acid phosphatase, HppA from Helicobacter pylori.
Sisodia R; Mazumdar PA; Madhurantakam C
J Mol Recognit; 2023 Sep; 36(9):e3049. PubMed ID: 37553866
[TBL] [Abstract][Full Text] [Related]
36. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
Mishra V; Pathak C
J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
[TBL] [Abstract][Full Text] [Related]
37. Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13.
Cruz JN; Costa JFS; Khayat AS; Kuca K; Barros CAL; Neto AMJC
J Biomol Struct Dyn; 2019 Apr; 37(6):1616-1627. PubMed ID: 29633908
[TBL] [Abstract][Full Text] [Related]
38. Novel and potent inhibitors for dihydropteroate synthase of
Satuluri SH; Katari SK; Pasala C; Amineni U
J Recept Signal Transduct Res; 2020 Jun; 40(3):246-256. PubMed ID: 32098568
[TBL] [Abstract][Full Text] [Related]
39. Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA.
González A; Salillas S; Velázquez-Campoy A; Espinosa Angarica V; Fillat MF; Sancho J; Lanas Á
Sci Rep; 2019 Aug; 9(1):11294. PubMed ID: 31383920
[TBL] [Abstract][Full Text] [Related]
40. A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.
Akash S; Aovi FI; Azad MAK; Kumer A; Chakma U; Islam MR; Mukerjee N; Rahman MM; Bayıl I; Rashid S; Sharma R
PLoS One; 2023; 18(10):e0283271. PubMed ID: 37824496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
